CSL has announced a leadership transition, with Chief Executive Officer and Managing Director Dr Paul McKenzie set to retire, marking the end of a seven-year executive tenure. …
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
CSL confirms leadership transition as Gordon Naylor steps in as interim CEO
February 10, 2026 - - Latest News -
BCEC partners with Life Sciences Queensland to launch bursary for next-gen bio innovation leaders
February 10, 2026 - - Australian Biotech -
Memphasys fast-tracks Australian market entry with early TGA approval for Felix system
February 10, 2026 - - Australian Biotech -
Algorae expands commercial footprint with new licensing deal
February 10, 2026 - - Australian Biotech -
Immutep reaches midpoint in global Phase 3 lung cancer trial
February 10, 2026 - - Australian Biotech -
Molecule2Market appoints inaugural CEO to lead next phase of growth
February 10, 2026 - - Australian Biotech -
Can we keep avoiding the simplest of all questions in a shifting medicines global order?
February 10, 2026 - - Latest News